# Greenspring Associates, LLC

> Institutional holdings reported to the SEC as of Q2 2021 on Form 13F. CIK 1796458. Source: https://holderbook.com/funds/1796458-greenspring-associates-llc/

- Reported value: $1.5B
- Positions: 13
- Weight of the ten largest: 100.0%
- Filed: 2021-08-13

A 13F reports long US equity positions only. Short positions, bonds, foreign listings, private holdings and cash are not visible, so this is not the manager's whole book.

## Holdings

| Security | Ticker | Value | Shares | Weight | Quarters held |
|---|---|---|---|---|---|
| BRIGHT HEALTH GROUP INC | [BHGXXXX](https://holderbook.com/stocks/BHGXXXX/) | $748.1M | 43,595,931 | 50.6% | 1 |
| WALKME LTD | [WKME](https://holderbook.com/stocks/WKME/) | $303.3M | 10,366,855 | 20.5% | 1 |
| XOMETRY INC | [XMTR](https://holderbook.com/stocks/XMTR/) | $241.9M | 2,768,466 | 16.4% | 1 |
| UIPATH INC | [PATH](https://holderbook.com/stocks/PATH/) | $125.1M | 1,842,177 | 8.5% | 1 |
| NGM BIOPHARMACEUTICALS INC | [NGM](https://holderbook.com/stocks/NGM/) | $31.0M | 1,573,357 | 2.1% | 9 |
| PHATHOM PHARMACEUTICALS INC | [PHAT](https://holderbook.com/stocks/PHAT/) | $14.1M | 415,277 | 1.0% | 7 |
| OBLONG INC | [OBLG](https://holderbook.com/stocks/OBLG/) | $12.6M | 3,692,661 | 0.8% | 2 |
| SMARTSHEET INC | [SMAR](https://holderbook.com/stocks/SMAR/) | $1.3M | 18,129 | 0.1% | 1 |
| ARCUTIS BIOTHERAPEUTICS INC | [ARQT](https://holderbook.com/stocks/ARQT/) | $961.0K | 35,210 | 0.1% | 1 |
| ZENDESK INC | [ZEN](https://holderbook.com/stocks/ZEN/) | $119.0K | 824 | 0.0% | 1 |
| FINVOLUTION GROUP | [FINV](https://holderbook.com/stocks/FINV/) | $118.0K | 12,412 | 0.0% | 2 |
| STITCH FIX INC | [SFIX](https://holderbook.com/stocks/SFIX/) | $86.0K | 1,433 | 0.0% | 1 |
| PROGYNY INC | [PGNY](https://holderbook.com/stocks/PGNY/) | $80.0K | 1,359 | 0.0% | 1 |

## What the disclosed book did

Not the fund's return. This is the change in value of the positions disclosed on Form 13F, had they been left untouched, against SPY over the same quarter ends.

| Quarter | Book | Market | Difference | Priced |
|---|---|---|---|---|
| Q2 2021 | -25.6% | +8.0% | -33.6% | 65% |
| Q1 2021 | +1.9% | +6.0% | -4.1% | 100% |
| Q4 2020 | +48.8% | +11.6% | +37.2% | 100% |
| Q3 2020 | +8.6% | +8.6% | +0.0% | 100% |
| Q2 2020 | +61.1% | +19.6% | +41.5% | 100% |
| Q1 2020 | -14.1% | -19.9% | +5.9% | 100% |
| Q4 2019 | -4.6% | +8.5% | -13.0% | 100% |
| Q3 2019 | -15.9% | +1.3% | -17.2% | 100% |

## Quarter by quarter

| Quarter | Value | Positions |
|---|---|---|
| Q2 2021 | $1.5B | 13 |
| Q1 2021 | $125.7M | 8 |
| Q4 2020 | $77.0M | 7 |
| Q3 2020 | $64.3M | 12 |
| Q2 2020 | $163.0M | 8 |
| Q1 2020 | $241.5M | 12 |
| Q4 2019 | $379.2M | 15 |
| Q3 2019 | $329.7M | 15 |
| Q2 2019 | $194.3M | 8 |
| Q1 2019 | $256.6M | 11 |